Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Infusion site extravasation? 435 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 435 reports of Infusion site extravasation have been filed in association with INFLIXIMAB (Renflexis). This represents 0.3% of all adverse event reports for INFLIXIMAB.

435
Reports of Infusion site extravasation with INFLIXIMAB
0.3%
of all INFLIXIMAB reports
9
Deaths
64
Hospitalizations

How Dangerous Is Infusion site extravasation From INFLIXIMAB?

Of the 435 reports, 9 (2.1%) resulted in death, 64 (14.7%) required hospitalization, and 1 (0.2%) were considered life-threatening.

Is Infusion site extravasation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 435 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Infusion site extravasation?

HUMAN IMMUNOGLOBULIN G (822) INFLIXIMAB-DYYB (328) TREPROSTINIL (256) VEDOLIZUMAB (199) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185) REMDESIVIR (144) FERRIC CARBOXYMALTOSE (118) RITUXIMAB (82) NATALIZUMAB (70) ECULIZUMAB (59)

Which INFLIXIMAB Alternatives Have Lower Infusion site extravasation Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Infusion site extravasation Reports All Drugs Causing Infusion site extravasation INFLIXIMAB Demographics